Skip to main content
Top
Published in: International Ophthalmology 5/2018

01-10-2018 | Case Report

Bilateral macular infarction after gemcitabine and carboplatin chemotherapy

Authors: Umesh Chandra Behera, Rohit R. Modi, Jenil Sheth, Arshi Singh

Published in: International Ophthalmology | Issue 5/2018

Login to get access

Abstract

Purpose

To report a case of macular infarction after doublet chemotherapy with gemcitabine and carboplatin.

Methods

A middle-aged lady presenting with bilateral macular infarction post-chemotherapy for metastatic cervical malignancy was investigated for thromboembolic risks and treated.

Results

The macular perfusion and edema improved with control of hypertension and treatment with pentoxifylline. Visual improvement was satisfactory, and the possible associated risk such as hypertension was noted.

Conclusion

This case underscores the need for active screening of patients on chemotherapy with gemcitabine and carboplatin for retinal vascular occlusive changes when hypertension is associated.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cavdar C, Toprak O, Oztop I, Secil M, Cokmert S, Camsari T (2007) Bilateral renal infarction in a patient with lung carcinoma treated with cisplatin and gemcitabine. Ren Fail 29:923–925CrossRefPubMed Cavdar C, Toprak O, Oztop I, Secil M, Cokmert S, Camsari T (2007) Bilateral renal infarction in a patient with lung carcinoma treated with cisplatin and gemcitabine. Ren Fail 29:923–925CrossRefPubMed
2.
go back to reference Banach MJ, Williams GA (2000) Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy. Arch Ophthalmol 118(5):726–727CrossRefPubMed Banach MJ, Williams GA (2000) Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy. Arch Ophthalmol 118(5):726–727CrossRefPubMed
3.
go back to reference Sheyman AT, Wald KJ, Pahk PJ, Freund KB (2014) Gemcitabine associated retinopathy and nephropathy. Retin Cases Brief Rep 8(2):107–109CrossRefPubMed Sheyman AT, Wald KJ, Pahk PJ, Freund KB (2014) Gemcitabine associated retinopathy and nephropathy. Retin Cases Brief Rep 8(2):107–109CrossRefPubMed
5.
go back to reference Shahab N, Haider S, Doll DC (2006) Vascular toxicity of antineoplastic agents. Semin Oncol 33:121–138CrossRefPubMed Shahab N, Haider S, Doll DC (2006) Vascular toxicity of antineoplastic agents. Semin Oncol 33:121–138CrossRefPubMed
6.
go back to reference O’Brien ME, Tonge K, Blake P, Moskovic E, Wiltshaw E (1992) Blindness associated with high-dose carboplatin. Lancet 339(8792):558CrossRefPubMed O’Brien ME, Tonge K, Blake P, Moskovic E, Wiltshaw E (1992) Blindness associated with high-dose carboplatin. Lancet 339(8792):558CrossRefPubMed
7.
go back to reference Tran TH, Desauw C, Rose C (2009) Gemcitabine-induced retinopathy in a diabetic patient. Acta Ophthalmol 87(1):114–115CrossRefPubMed Tran TH, Desauw C, Rose C (2009) Gemcitabine-induced retinopathy in a diabetic patient. Acta Ophthalmol 87(1):114–115CrossRefPubMed
8.
go back to reference Agustoni F, Platania M, Vitali M et al (2014) Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders. Cancer Treat Rev 40(1):197–203CrossRefPubMed Agustoni F, Platania M, Vitali M et al (2014) Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders. Cancer Treat Rev 40(1):197–203CrossRefPubMed
Metadata
Title
Bilateral macular infarction after gemcitabine and carboplatin chemotherapy
Authors
Umesh Chandra Behera
Rohit R. Modi
Jenil Sheth
Arshi Singh
Publication date
01-10-2018
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 5/2018
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0698-9

Other articles of this Issue 5/2018

International Ophthalmology 5/2018 Go to the issue